{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:41:28Z","timestamp":1794004888675,"version":"4.8.0"},"reference-count":150,"publisher":"Oxford University Press (OUP)","issue":"32","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100019896","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"Singapore Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CG21APR1006"],"award-info":[{"award-number":["CG21APR1006"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CG21APRC006"],"award-info":[{"award-number":["CG21APRC006"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-000230"],"award-info":[{"award-number":["MOH-000230"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CArdiovascular DiseasE National Collaborative Enterprise"},{"name":"National Clinical Translational Program","award":["MOH-001277-01"],"award-info":[{"award-number":["MOH-001277-01"]}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["CRP25-2020RS-0001"],"award-info":[{"award-number":["CRP25-2020RS-0001"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100028802","name":"A*STAR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiovascular diseases (CVD) are the leading causes of death and disability worldwide with their global burden on the rise due to the ageing population and escalating prevalence of CVD risk factors, such as diabetes, obesity, hypertension, and hyperlipidaemia. As such, new treatments are urgently needed to improve health outcomes in patients with CVD. However, the efficacy of emerging medical and advanced therapies for CVD may be hampered by their inadequate delivery to the heart. Established delivery strategies such as intramyocardial injection and catheter-based intracoronary delivery technologies require an invasive intervention, thereby limiting their clinical application. Although cardiotropic adeno-associated virus vectors, which target therapeutics to the heart are less invasive they have their own challenges in terms of immunogenicity. This article provides a state-of-the-art review of the recent advances in cardiac-targeting delivery systems including local intracoronary catheter-based delivery, cardiotropic adeno-associated viruses, extracellular vesicles, microbubbles, and nanoparticle delivery platforms, which have emerged as promising approaches for targeting the delivery of medical and advanced therapies such as small molecules, biologics, nucleic acid therapeutics, and gene therapies to the heart to combat CVD. However, challenges concerning immunogenicity, off-target effects, and delivery efficiency must be overcome to realize their therapeutic potential as safe and effective therapies. By leveraging surface modifications, cardiac-homing peptides, membrane cloaking, and organ-targeting technologies, the emerging cardiac-targeting delivery systems promise more effective medical and advanced therapies for a wide range of CVD, including ischaemic heart disease, heart failure, and cardiac arrhythmias.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehag432","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:06:36Z","timestamp":1778673996000},"page":"4410-4426","source":"Crossref","is-referenced-by-count":3,"title":["Cardiac-targeted delivery of advanced medical therapies for heart disease"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8252-3435","authenticated-orcid":false,"given":"Xiao","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University , Guangzhou, Guangdong ,","place":["China"]},{"name":"National Heart Research Institute Singapore, National Heart Centre , 5 Hospital Drive, Singapore169609 ,","place":["Singapore"]},{"name":"Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School , 8 College Road, Singapore 169857 ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5810-9174","authenticated-orcid":false,"given":"Yan","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University , Guangzhou, Guangdong ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3365-6383","authenticated-orcid":false,"given":"Shengjie","family":"Lu","sequence":"additional","affiliation":[{"name":"National Heart Research Institute Singapore, National Heart Centre , 5 Hospital Drive, Singapore169609 ,","place":["Singapore"]},{"name":"Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School , 8 College Road, Singapore 169857 ,","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0729-4956","authenticated-orcid":false,"given":"Derek J","family":"Hausenloy","sequence":"additional","affiliation":[{"name":"National Heart Research Institute Singapore, National Heart Centre , 5 Hospital Drive, Singapore169609 ,","place":["Singapore"]},{"name":"Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School , 8 College Road, Singapore 169857 ,","place":["Singapore"]},{"name":"Yong Loo Lin School of Medicine, National University Singapore , 1E Kent Ridge Road, Singapore 119228 ,","place":["Singapore"]},{"name":"The Hatter Cardiovascular Institute, University College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"2026082319572044100_ehag432-B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5334\/gh.1288","article-title":"The heart of the world","volume":"19","author":"Di Cesare","year":"2024","journal-title":"Glob Heart"},{"key":"2026082319572044100_ehag432-B2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12951-024-02485-6","article-title":"Engineered nanoparticles promote cardiac tropism of AAV vectors","volume":"22","author":"Switala","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"2026082319572044100_ehag432-B3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12265-024-10553-3","article-title":"Intrapericardial administration to achieve localized and targeted treatment for cardiac disease","volume":"18","author":"Xu","year":"2025","journal-title":"J Cardiovasc Transl Res"},{"key":"2026082319572044100_ehag432-B4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.xjon.2022.04.043","article-title":"Therapeutic payload delivery to the myocardium: evolving strategies and obstacles","volume":"10","author":"Shazly","year":"2022","journal-title":"JTCVS Open"},{"key":"2026082319572044100_ehag432-B5","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2021.784731","article-title":"The grand challenges in cardiovascular drug delivery","volume":"1","author":"Cicha","year":"2021","journal-title":"Front Drug Deliv"},{"key":"2026082319572044100_ehag432-B6","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.3390\/ijms24065205","article-title":"Nanoparticles in the new era of cardiovascular therapeutics: challenges and opportunities","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026082319572044100_ehag432-B7","doi-asserted-by":"publisher","first-page":"742315","DOI":"10.3389\/fcvm.2021.742315","article-title":"De novo drug delivery modalities for treating damaged hearts: current challenges and emerging solutions","volume":"8","author":"Alvi","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026082319572044100_ehag432-B8","doi-asserted-by":"publisher","first-page":"112161","DOI":"10.1016\/j.cellsig.2025.112161","article-title":"Advances in cardiac cell interaction studies: implications for heart disease treatment","volume":"136","author":"Huang","year":"2025","journal-title":"Cell Signal"},{"key":"2026082319572044100_ehag432-B9","doi-asserted-by":"publisher","first-page":"9894","DOI":"10.1007\/s12274-023-5846-0","article-title":"Early initiation of ARBs without blood pressure risk via neutrophil membrane-fused pH-sensitive liposomes to reduce cardiomyocyte apoptosis after acute myocardial infarction","volume":"16","author":"Gao","year":"2023","journal-title":"Nano Res"},{"key":"2026082319572044100_ehag432-B10","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.2147\/DDDT.S371506","article-title":"Appropriate dose of dapagliflozin improves cardiac outcomes by normalizing mitochondrial fission and reducing cardiomyocyte apoptosis after acute myocardial infarction","volume":"16","author":"Fan","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"2026082319572044100_ehag432-B11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jare.2024.01.012","article-title":"Hspa12a acts as a scaffolding protein to inhibit cardiac fibroblast activation and cardiac fibrosis","volume":"67","author":"Mao","year":"2025","journal-title":"J Adv Res"},{"key":"2026082319572044100_ehag432-B12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00395-011-0228-2","article-title":"Cyclic nucleotide phosphodiesterase 1a: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart","volume":"106","author":"Miller","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"2026082319572044100_ehag432-B13","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1038\/s41467-022-30630-y","article-title":"Cardiac fibroblasts regulate the development of heart failure via htra3-tgf-\u03b2-igfbp7 axis","volume":"13","author":"Ko","year":"2022","journal-title":"Nat Commun"},{"key":"2026082319572044100_ehag432-B14","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1093\/eurheartj\/ehaf902","article-title":"Cardiac fibroblasts in myocardial injury and heart failure","volume":"47","author":"Van Linthout","year":"2025;","journal-title":"Eur Heart J."},{"key":"2026082319572044100_ehag432-B15","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/eurheartj\/ehae699","article-title":"An endogenous cholinergic system controls electrical conduction in the heart","volume":"46","author":"Xie","year":"2025","journal-title":"Eur Heart J"},{"key":"2026082319572044100_ehag432-B16","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411987","article-title":"P21-activated kinase 2 as a novel target for ventricular tachyarrhythmias associated with cardiac adrenergic stress and hypertrophy","volume":"12","author":"Li","year":"2025","journal-title":"Adv Sci"},{"key":"2026082319572044100_ehag432-B17","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1161\/CIRCULATIONAHA.125.075402","article-title":"Direct therapeutic modulation of RYR2 activity by CMYA5","volume":"152","author":"Lu","year":"2025","journal-title":"Circulation"},{"key":"2026082319572044100_ehag432-B18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jconrel.2015.06.017","article-title":"Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction","volume":"220","author":"Dasa","year":"2015","journal-title":"J Control Release"},{"key":"2026082319572044100_ehag432-B19","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.7150\/thno.20524","article-title":"Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide","volume":"8","author":"Vandergriff","year":"2018","journal-title":"Theranostics"},{"key":"2026082319572044100_ehag432-B20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"2026082319572044100_ehag432-B21","doi-asserted-by":"publisher","first-page":"102384","DOI":"10.1016\/j.redox.2022.102384","article-title":"Notoginsenoside r1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction","volume":"54","author":"Li","year":"2022","journal-title":"Redox Biol"},{"key":"2026082319572044100_ehag432-B22","doi-asserted-by":"publisher","first-page":"11275","DOI":"10.2147\/IJN.S478276","article-title":"Engineered biomimetic nanoparticles-mediated targeting delivery of allicin against myocardial ischemia-reperfusion injury by inhibiting ferroptosis","volume":"19","author":"Li","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"2026082319572044100_ehag432-B23","doi-asserted-by":"publisher","first-page":"26614","DOI":"10.1021\/acsnano.4c04814","article-title":"Platelet and erythrocyte membranes coassembled biomimetic nanoparticles for heart failure treatment","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"2026082319572044100_ehag432-B24","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70344","article-title":"Fibroblasts-specific p16(INK4a) exacerbates inflammageing-mediated post-infarction ventricular remodelling through interacting with STAT3 to regulate NLRP3 transcription","volume":"15","author":"Gu","year":"2025","journal-title":"Clin Transl Med"},{"key":"2026082319572044100_ehag432-B25","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"key":"2026082319572044100_ehag432-B26","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.jacc.2017.08.013","article-title":"Protein phosphatase inhibitor-1 gene therapy in a swine model of nonischemic heart failure","volume":"70","author":"Watanabe","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026082319572044100_ehag432-B27","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jconrel.2024.04.018","article-title":"Cardiac delivery of modified mRNA using lipid nanoparticles: cellular targets and biodistribution after intramyocardial administration","volume":"369","author":"Labonia","year":"2024","journal-title":"J Control Release"},{"key":"2026082319572044100_ehag432-B28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jconrel.2024.08.030","article-title":"Enhancing RNA-lipid nanoparticle delivery: organ- and cell-specificity and barcoding strategies","volume":"375","author":"Wei","year":"2024","journal-title":"J Control Release"},{"key":"2026082319572044100_ehag432-B29","doi-asserted-by":"publisher","first-page":"11185","DOI":"10.1021\/jacs.3c01054","article-title":"Inflammation-responsive micellar nanoparticles from degradable polyphosphoramidates for targeted delivery to myocardial infarction","volume":"145","author":"Liang","year":"2023","journal-title":"J Am Chem Soc"},{"key":"2026082319572044100_ehag432-B30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12951-022-01457-y","article-title":"Heart-targeted amelioration of sepsis-induced myocardial dysfunction by microenvironment responsive nitric oxide nanogenerators in situ","volume":"20","author":"Ouyang","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"2026082319572044100_ehag432-B31","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/s41467-024-50312-1","article-title":"Inhalable cardiac targeting peptide modified nanomedicine prevents pressure overload heart failure in male mice","volume":"15","author":"Weng","year":"2024","journal-title":"Nat Commun"},{"key":"2026082319572044100_ehag432-B32","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.ultrasmedbio.2020.01.002","article-title":"Ultrasound-responsive cavitation nuclei for therapy and drug delivery","volume":"46","author":"Kooiman","year":"2020","journal-title":"Ultrasound Med Biol"},{"key":"2026082319572044100_ehag432-B33","doi-asserted-by":"publisher","first-page":"8003","DOI":"10.1039\/C5NR01050K","article-title":"Silica-gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial","volume":"7","author":"Kharlamov","year":"2015","journal-title":"Nanoscale"},{"key":"2026082319572044100_ehag432-B34","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/eurheartj\/ehad636","article-title":"Intracoronary delivery of extracellular vesicles from human cardiac progenitor cells reduces infarct size in porcine acute myocardial infarction","volume":"45","author":"Emmert","year":"2024","journal-title":"Eur Heart J"},{"key":"2026082319572044100_ehag432-B35","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1016\/j.jacc.2021.04.028","article-title":"Antimir-132 attenuates myocardial hypertrophy in an animal model of percutaneous aortic constriction","volume":"77","author":"Hinkel","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026082319572044100_ehag432-B36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-981-13-1114-7_22","volume-title":"Primary Angioplasty: A Practical Guide","author":"Paradies","year":"2018"},{"key":"2026082319572044100_ehag432-B37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamacardio.2016.0008","article-title":"Intracoronary gene transfer of adenylyl cyclase 6 in patients with heart failure: a randomized clinical trial","volume":"1","author":"Hammond","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026082319572044100_ehag432-B38","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202300603","article-title":"Intravascularly deliverable biomaterial platforms for tissue repair and regeneration post-myocardial infarction","volume":"36","author":"Chen","year":"2024","journal-title":"Adv Mater"},{"key":"2026082319572044100_ehag432-B39","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.1128\/JVI.07232-11","article-title":"Structural insight into the unique properties of adeno-associated virus serotype 9","volume":"86","author":"DiMattia","year":"2012","journal-title":"J Virol"},{"key":"2026082319572044100_ehag432-B40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41591-022-02176-5","article-title":"Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice","volume":"29","author":"Chai","year":"2023","journal-title":"Nat Med"},{"key":"2026082319572044100_ehag432-B41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/CIRCULATIONAHA.123.065624","article-title":"In vivo base editing of scn5a rescues type 3 long QT syndrome in mice","volume":"149","author":"Qi","year":"2024","journal-title":"Circulation"},{"key":"2026082319572044100_ehag432-B42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175164","article-title":"CRISPR-Cas9 base editing of pathogenic CaMKII\u03b4 improves cardiac function in a humanized mouse model","volume":"134","author":"Lebek","year":"2024","journal-title":"J Clin Invest"},{"key":"2026082319572044100_ehag432-B43","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1073\/pnas.1018925108","article-title":"Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart","volume":"108","author":"Tao","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026082319572044100_ehag432-B44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.gene.2019.01.044","article-title":"Adeno-associated virus 9-mediated RNA interference targeting SOCS3 alleviates diastolic heart failure in rats","volume":"697","author":"Gao","year":"2019","journal-title":"Gene"},{"key":"2026082319572044100_ehag432-B45","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70199","article-title":"Fibroblast-derived miR-425-5p alleviates cardiac remodelling in heart failure via inhibiting the TGF-\u03b21\/Smad signalling","volume":"28","author":"Zhou","year":"2024","journal-title":"J Cell Mol Med"},{"key":"2026082319572044100_ehag432-B46","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf3136","article-title":"Gene therapy targeting protein trafficking regulator MOG1 in mouse models of Brugada syndrome, arrhythmias, and mild cardiomyopathy","volume":"14","author":"Yu","year":"2022","journal-title":"Sci Transl Med"},{"key":"2026082319572044100_ehag432-B47","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-019-1191-6","article-title":"Microrna therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs","volume":"569","author":"Gabisonia","year":"2019","journal-title":"Nature"},{"key":"2026082319572044100_ehag432-B48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd6892","article-title":"Gene therapy knockdown of hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction","volume":"13","author":"Liu","year":"2021","journal-title":"Sci Transl Med"},{"key":"2026082319572044100_ehag432-B49","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1093\/cvr\/cvaf109","article-title":"Gene therapy in cardiac and vascular diseases: a review of approaches to treat genetic and common cardiovascular diseases with novel gene-based therapeutics","volume":"121","author":"Musolino","year":"2025","journal-title":"Cardiovasc Res"},{"key":"2026082319572044100_ehag432-B50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"key":"2026082319572044100_ehag432-B51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/CIRCRESAHA.113.302421","article-title":"Long-term effects of AAV1\/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality","volume":"114","author":"Zsebo","year":"2014","journal-title":"Circ Res"},{"key":"2026082319572044100_ehag432-B52","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1038\/s41591-025-04011-z","article-title":"Cardiotropic AAV gene therapy for heart failure: a phase 1 trial","volume":"31","author":"Henry","year":"2025","journal-title":"Nat Med"},{"key":"2026082319572044100_ehag432-B53","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1056\/NEJMoa2412392","article-title":"Phase 1 study of AAV9.LAMP2B gene therapy in Danon disease","volume":"392","author":"Greenberg","year":"2025","journal-title":"N Engl J Med"},{"key":"2026082319572044100_ehag432-B54","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/14712598.2022.2060737","article-title":"Addressing high dose AAV toxicity - \u2018one and done\u2019 or \u2018slower and lower'?","volume":"22","author":"Kishimoto","year":"2022","journal-title":"Expert Opin Biol Ther"},{"key":"2026082319572044100_ehag432-B55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/hum.2017.095","article-title":"Dual AAV gene therapy for Duchenne muscular dystrophy with a 7-kb mini-dystrophin gene in the canine model","volume":"29","author":"Kodippili","year":"2018","journal-title":"Hum Gene Ther"},{"key":"2026082319572044100_ehag432-B56","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1089\/hum.2017.144","article-title":"Cardiac-specific expression of \u03b4H2-R15 mini-dystrophin normalized all electrocardiogram abnormalities and the end-diastolic volume in a 23-month-old mouse model of Duchenne dilated cardiomyopathy","volume":"29","author":"Wasala","year":"2018","journal-title":"Hum Gene Ther"},{"key":"2026082319572044100_ehag432-B57","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1089\/hum.2013.210","article-title":"Full-length dystrophin reconstitution with adeno-associated viral vectors","volume":"25","author":"Lostal","year":"2014","journal-title":"Hum Gene Ther"},{"key":"2026082319572044100_ehag432-B58","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s41467-026-68469-2","article-title":"Coiled-coil heterodimer-mediated split base editing systems enable flexible and robust nucleotide substitutions","volume":"17","author":"Mu","year":"2026","journal-title":"Nat Commun"},{"key":"2026082319572044100_ehag432-B59","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1161\/CIRCULATIONAHA.123.065438","article-title":"Microrna-122-mediated liver detargeting enhances the tissue specificity of cardiac genome editing","volume":"149","author":"Yang","year":"2024","journal-title":"Circulation"},{"key":"2026082319572044100_ehag432-B60","doi-asserted-by":"publisher","first-page":"10450","DOI":"10.1038\/s41467-024-54635-x","article-title":"AAV delivery strategy with mechanical support for safe and efficacious cardiac gene transfer in swine","volume":"15","author":"Mazurek","year":"2024","journal-title":"Nat Commun"},{"key":"2026082319572044100_ehag432-B61","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41434-025-00512-1","article-title":"Safety, efficacy, and immunogenicity of a novel igg degrading enzyme (kj103): results from two randomised, blinded, phase 1 clinical trials","volume":"32","author":"Cao","year":"2025","journal-title":"Gene Ther"},{"key":"2026082319572044100_ehag432-B62","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ajt.2022.11.025","article-title":"First use of imlifidase desensitization in a highly sensitized lung transplant candidate: a case report","volume":"23","author":"Roux","year":"2023","journal-title":"Am J Transplant"},{"key":"2026082319572044100_ehag432-B63","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-020-0911-7","article-title":"IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies","volume":"26","author":"Leborgne","year":"2020","journal-title":"Nat Med"},{"key":"2026082319572044100_ehag432-B64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/cvr\/cvx211","article-title":"Extracellular vesicles in diagnostics and therapy of the ischaemic heart: position paper from the working group on cellular biology of the heart of the European Society of Cardiology","volume":"114","author":"Sluijter","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2026082319572044100_ehag432-B65","first-page":"227","article-title":"Extracellular vesicles - mediating and delivering cardioprotection in acute myocardial infarction and heart failure","volume":"3","author":"Prakash","year":"2020","journal-title":"Cond Med"},{"key":"2026082319572044100_ehag432-B66","doi-asserted-by":"publisher","first-page":"1041481","DOI":"10.3389\/fcvm.2022.1041481","article-title":"Extracellular vesicles: targeting the heart","volume":"9","author":"Yin","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026082319572044100_ehag432-B67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12951-018-0388-4","article-title":"Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display","volume":"16","author":"Antes","year":"2018","journal-title":"J Nanobiotechnology"},{"key":"2026082319572044100_ehag432-B68","doi-asserted-by":"publisher","first-page":"10041","DOI":"10.1038\/s41598-019-46407-1","article-title":"Exosomes engineered to express a cardiomyocyte binding peptide demonstrate improved cardiac retention in vivo","volume":"9","author":"Mentkowski","year":"2019","journal-title":"Sci Rep"},{"key":"2026082319572044100_ehag432-B69","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.omtn.2021.04.018","article-title":"Improved cardiac-specific delivery of RAGE siRNA within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditis","volume":"24","author":"Kim","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"2026082319572044100_ehag432-B70","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.bbrc.2018.03.227","article-title":"Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes","volume":"499","author":"Kim","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"2026082319572044100_ehag432-B71","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008737","article-title":"Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction","volume":"7","author":"Wang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026082319572044100_ehag432-B72","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12371","article-title":"Engineered small extracellular vesicle-mediated NOX4 siRNA delivery for targeted therapy of cardiac hypertrophy","volume":"12","author":"Kang","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"2026082319572044100_ehag432-B73","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jconrel.2024.05.023","article-title":"Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing","volume":"370","author":"Mun","year":"2024","journal-title":"J Control Release"},{"key":"2026082319572044100_ehag432-B74","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12951-022-01630-3","article-title":"Heart-targeting exosomes from human cardiosphere-derived cells improve the therapeutic effect on cardiac hypertrophy","volume":"20","author":"Mao","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"2026082319572044100_ehag432-B75","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12951-024-02631-0","article-title":"Targeting delivery of miR-146a via IMTP modified milk exosomes exerted cardioprotective effects by inhibiting NF-\u03baB signaling pathway after myocardial ischemia-reperfusion injury","volume":"22","author":"Meng","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"2026082319572044100_ehag432-B76","doi-asserted-by":"publisher","first-page":"101210","DOI":"10.1016\/j.nantod.2021.101210","article-title":"Platelet membrane and stem cell exosome hybrid enhances cellular uptake and targeting to heart injury","volume":"39","author":"Hu","year":"2021","journal-title":"Nano Today"},{"key":"2026082319572044100_ehag432-B77","doi-asserted-by":"publisher","first-page":"120168","DOI":"10.1016\/j.biomaterials.2020.120168","article-title":"Monocyte mimics improve mesenchymal stem cell-derived extracellular vesicle homing in a mouse MI\/RI model","volume":"255","author":"Zhang","year":"2020","journal-title":"Biomaterials"},{"key":"2026082319572044100_ehag432-B78","doi-asserted-by":"publisher","first-page":"105145","DOI":"10.1016\/j.ebiom.2024.105145","article-title":"First-in-man use of a cardiovascular cell-derived secretome in heart failure. Case report","volume":"103","author":"Menasch\u00e9","year":"2024","journal-title":"EBioMedicine"},{"key":"2026082319572044100_ehag432-B79","doi-asserted-by":"publisher","first-page":"8609","DOI":"10.7150\/thno.113474","article-title":"Synergistic integration of extracellular vesicles and metal-organic frameworks: unlocking new opportunities in disease diagnosis and therapy","volume":"15","author":"Xu","year":"2025","journal-title":"Theranostics"},{"key":"2026082319572044100_ehag432-B80","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1161\/01.CIR.101.22.2554","article-title":"Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium","volume":"101","author":"Shohet","year":"2000","journal-title":"Circulation"},{"key":"2026082319572044100_ehag432-B81","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0735-1097(03)00627-2","article-title":"Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction","volume":"42","author":"Chen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026082319572044100_ehag432-B82","doi-asserted-by":"publisher","first-page":"2594555","DOI":"10.1080\/10717544.2025.2594555","article-title":"Breakthroughs of ultrasound-targeted microbubble destruction in treating myocardial ischemia-reperfusion injury: from angiogenesis regulation to precise inflammation suppression","volume":"32","author":"Feng","year":"2025","journal-title":"Drug Deliv"},{"key":"2026082319572044100_ehag432-B83","doi-asserted-by":"publisher","first-page":"114823","DOI":"10.1016\/j.jconrel.2026.114823","article-title":"Application of ultrasound-targeted microbubble destruction in thrombus therapy","volume":"393","author":"Huang","year":"2026","journal-title":"J Control Release"},{"key":"2026082319572044100_ehag432-B84","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/01.CIR.0000084535.35435.AE","article-title":"Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart","volume":"108","author":"Bekeredjian","year":"2003","journal-title":"Circulation"},{"key":"2026082319572044100_ehag432-B85","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jcmg.2009.04.008","article-title":"Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice","volume":"2","author":"Fujii","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026082319572044100_ehag432-B86","doi-asserted-by":"publisher","first-page":"131943","DOI":"10.1016\/j.ijcard.2024.131943","article-title":"Ultrasound-targeted microbubble destruction rapidly improves left ventricular function in rats with ischemic cardiac dysfunction","volume":"404","author":"Cai","year":"2024","journal-title":"Int J Cardiol"},{"key":"2026082319572044100_ehag432-B87","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.actbio.2023.04.020","article-title":"Cardioprotective effect of ultrasound-targeted destruction of sirt3-loaded cationic microbubbles in a large animal model of pathological cardiac hypertrophy","volume":"164","author":"Qin","year":"2023","journal-title":"Acta Biomater"},{"key":"2026082319572044100_ehag432-B88","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.7150\/thno.34895","article-title":"Ultrasound and microbubble-targeted delivery of a microRNA inhibitor to the heart suppresses cardiac hypertrophy and preserves cardiac function","volume":"9","author":"Kopechek","year":"2019","journal-title":"Theranostics"},{"key":"2026082319572044100_ehag432-B89","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jconrel.2015.11.020","article-title":"Increased local delivery of antagomir therapeutics to the rodent myocardium using ultrasound and microbubbles","volume":"222","author":"Kwekkeboom","year":"2016","journal-title":"J Control Release"},{"key":"2026082319572044100_ehag432-B90","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.3892\/etm.2017.4270","article-title":"Ultrasound combined with targeted cationic microbubble-mediated angiogenesis gene transfection improves ischemic heart function","volume":"13","author":"Zhou","year":"2017","journal-title":"Exp Ther Med"},{"key":"2026082319572044100_ehag432-B91","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1631\/jzus.B1700298","article-title":"Use of cationic microbubbles targeted to p-selectin to improve ultrasound-mediated gene transfection of hVEGF(165) to the ischemic myocardium","volume":"19","author":"Shentu","year":"2018","journal-title":"J Zhejiang Univ Sci B"},{"key":"2026082319572044100_ehag432-B92","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12951-023-02204-7","article-title":"Ultrasound-targeted microbubble destruction promotes PDGF-primed bone mesenchymal stem cell transplantation for myocardial protection in acute myocardial infarction in rats","volume":"21","author":"Sun","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"2026082319572044100_ehag432-B93","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/10717544.2018.1534898","article-title":"Efficient exosome delivery in refractory tissues assisted by ultrasound-targeted microbubble destruction","volume":"26","author":"Sun","year":"2019","journal-title":"Drug Deliv"},{"key":"2026082319572044100_ehag432-B94","doi-asserted-by":"publisher","first-page":"122775","DOI":"10.1016\/j.biomaterials.2024.122775","article-title":"MSCs biomimetic ultrasonic phase change nanoparticles promotes cardiac functional recovery after acute myocardial infarction","volume":"313","author":"Wang","year":"2025","journal-title":"Biomaterials"},{"key":"2026082319572044100_ehag432-B95","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1016\/j.jacc.2019.03.006","article-title":"Sonothrombolysis in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"73","author":"Mathias","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026082319572044100_ehag432-B96","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.119.009536","article-title":"Sonothrombolysis improves myocardial dynamics and microvascular obstruction preventing left ventricular remodeling in patients with ST elevation myocardial infarction","volume":"13","author":"Aguiar","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026082319572044100_ehag432-B97","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.biomaterials.2007.12.033","article-title":"Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model","volume":"29","author":"Zhang","year":"2008","journal-title":"Biomaterials"},{"key":"2026082319572044100_ehag432-B98","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1021\/nl2025882","article-title":"Nanoparticles targeting the infarcted heart","volume":"11","author":"Dvir","year":"2011","journal-title":"Nano Lett"},{"key":"2026082319572044100_ehag432-B99","doi-asserted-by":"publisher","first-page":"H1124","DOI":"10.1152\/ajpheart.00707.2012","article-title":"Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits","volume":"304","author":"Yamada","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026082319572044100_ehag432-B100","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12951-022-01433-6","article-title":"Targeted neutrophil-mimetic liposomes promote cardiac repair by adsorbing proinflammatory cytokines and regulating the immune microenvironment","volume":"20","author":"Chen","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"2026082319572044100_ehag432-B101","doi-asserted-by":"publisher","first-page":"7997","DOI":"10.2147\/IJN.S468394","article-title":"Puerarin-loaded liposomes co-modified by ischemic myocardium-targeting peptide and triphenylphosphonium cations ameliorate myocardial ischemia-reperfusion injury","volume":"19","author":"Wang","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"2026082319572044100_ehag432-B102","doi-asserted-by":"publisher","first-page":"7509","DOI":"10.7150\/thno.77259","article-title":"Lipid nanoparticles for delivery of RNA therapeutics: current status and the role of in vivo imaging","volume":"12","author":"Jung","year":"2022","journal-title":"Theranostics"},{"key":"2026082319572044100_ehag432-B103","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/bph.16262","article-title":"Cardiac side effects of RNA-based sars-cov-2 vaccines: hidden cardiotoxic effects of mRNA-1273 and BNT162b2 on ventricular myocyte function and structure","volume":"181","author":"Schreckenberg","year":"2024","journal-title":"Br J Pharmacol"},{"key":"2026082319572044100_ehag432-B104","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jconrel.2022.01.027","article-title":"Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles","volume":"343","author":"Evers","year":"2022","journal-title":"J Control Release"},{"key":"2026082319572044100_ehag432-B105","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409266122","article-title":"Systemic delivery of biotherapeutic RNA to the myocardium transiently modulates cardiac contractility in vivo","volume":"122","author":"Shuvaev","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026082319572044100_ehag432-B106","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jconrel.2019.10.028","article-title":"Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening","volume":"316","author":"Guimaraes","year":"2019","journal-title":"J Control Release"},{"key":"2026082319572044100_ehag432-B107","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat Protoc"},{"key":"2026082319572044100_ehag432-B108","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s41565-025-01975-4","article-title":"Designing lipid nanoparticles using a transformer-based neural network","volume":"20","author":"Chan","year":"2025","journal-title":"Nat Nanotechnol"},{"key":"2026082319572044100_ehag432-B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-025-01523-4","article-title":"A microphysiological system for screening lipid nanoparticle-mRNA complexes predicts in vivo heart transfection efficacy","author":"Neiman","year":"2025","journal-title":"Nat Biomed Eng"},{"key":"2026082319572044100_ehag432-B110","doi-asserted-by":"publisher","first-page":"123410","DOI":"10.1016\/j.biomaterials.2025.123410","article-title":"LNPs-mediated VEGF-C mRNA delivery promotes heart repair and attenuates inflammation by stimulating lymphangiogenesis post-myocardial infarction","volume":"322","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"key":"2026082319572044100_ehag432-B111","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.2147\/IJN.S366962","article-title":"Ionizable lipid nanoparticle-mediated delivery of plasmid DNA in cardiomyocytes","volume":"17","author":"Scalzo","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"2026082319572044100_ehag432-B112","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/biology13010047","article-title":"Peptide-guided nanoparticle drug delivery for cardiomyocytes","volume":"13","author":"Li","year":"2024","journal-title":"Biology (Basel)"},{"key":"2026082319572044100_ehag432-B113","doi-asserted-by":"publisher","first-page":"22659","DOI":"10.1021\/jacs.3c07811","article-title":"Modular bioorthogonal lipid nanoparticle modification platforms for cardiac homing","volume":"145","author":"Cruz-Samperio","year":"2023","journal-title":"J Am Chem Soc"},{"key":"2026082319572044100_ehag432-B114","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/cvr\/cvaf039","article-title":"Targeted delivery of TAPI-1 via biomimetic nanoparticles ameliorates post-infarct left ventricle function and remodelling","volume":"121","author":"Chen","year":"2025","journal-title":"Cardiovasc Res"},{"key":"2026082319572044100_ehag432-B115","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf2400","article-title":"Immune cell shuttle for precise delivery of nanotherapeutics for heart disease and cancer","volume":"7","author":"Huang","year":"2021","journal-title":"Sci Adv"},{"key":"2026082319572044100_ehag432-B116","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/CIRCRESAHA.125.326716","article-title":"Car macrophages engineered in vivo for attenuating myocardial ischemia-reperfusion injury","volume":"137","author":"Du","year":"2025","journal-title":"Circ Res"},{"key":"2026082319572044100_ehag432-B117","doi-asserted-by":"publisher","first-page":"113623","DOI":"10.1016\/j.jconrel.2025.113623","article-title":"Effective transcatheter intracoronary delivery of mRNA-lipid nanoparticles targeting the heart","volume":"381","author":"Handa","year":"2025","journal-title":"J Control Release"},{"key":"2026082319572044100_ehag432-B118","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/13543784.2024.2369747","article-title":"VERVE-101, a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol","volume":"33","author":"Hooper","year":"2024","journal-title":"Expert Opin Investig Drugs"},{"key":"2026082319572044100_ehag432-B119","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jconrel.2015.01.008","article-title":"A spatio-temporal cardiomyocyte targeted vector system for efficient delivery of therapeutic payloads to regress cardiac hypertrophy abating bystander effect","volume":"200","author":"Rana","year":"2015","journal-title":"J Control Release"},{"key":"2026082319572044100_ehag432-B120","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.nano.2017.12.004","article-title":"Delivery of microRNA-1 inhibitor by dendrimer-based nanovector: an early targeting therapy for myocardial infarction in mice","volume":"14","author":"Xue","year":"2018","journal-title":"Nanomedicine"},{"key":"2026082319572044100_ehag432-B121","doi-asserted-by":"publisher","first-page":"8107","DOI":"10.1021\/acsnano.3c11661","article-title":"One endothelium-targeted combined nucleic acid delivery system for myocardial infarction therapy","volume":"18","author":"Shao","year":"2024","journal-title":"ACS Nano"},{"key":"2026082319572044100_ehag432-B122","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1021\/acs.bioconjchem.8b00882","article-title":"A supramolecular nanocarrier for delivery of amiodarone anti-arrhythmic therapy to the heart","volume":"30","author":"Ahmed","year":"2019","journal-title":"Bioconjug Chem"},{"key":"2026082319572044100_ehag432-B123","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1021\/acsnano.2c10042","article-title":"Cysteine-based redox-responsive nanoparticles for fibroblast-targeted drug delivery in the treatment of myocardial infarction","volume":"17","author":"Ji","year":"2023","journal-title":"ACS Nano"},{"key":"2026082319572044100_ehag432-B124","doi-asserted-by":"publisher","first-page":"881320","DOI":"10.3389\/fphar.2022.881320","article-title":"Red blood cell membrane-camouflaged PLGA nanoparticles loaded with basic fibroblast growth factor for attenuating sepsis-induced cardiac injury","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026082319572044100_ehag432-B125","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bioactmat.2025.06.055","article-title":"Stromal-platelet membrane-inspired nanoparticles (SPIN) for targeted heart repair","volume":"53","author":"He","year":"2025","journal-title":"Bioact Mater"},{"key":"2026082319572044100_ehag432-B126","doi-asserted-by":"publisher","first-page":"47145","DOI":"10.1021\/acsomega.4c07573","article-title":"Targeted treatment of myocardial infarction by macrophage membrane coated with resveratrol nanoparticles","volume":"9","author":"Li","year":"2024","journal-title":"ACS Omega"},{"key":"2026082319572044100_ehag432-B127","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/ijms25021001","article-title":"Metal-based nanoparticles for cardiovascular diseases","volume":"25","author":"Scafa Udri\u0219te","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026082319572044100_ehag432-B128","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1878-5085-4-20","article-title":"Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology","volume":"4","author":"Spivak","year":"2013","journal-title":"EPMA J"},{"key":"2026082319572044100_ehag432-B129","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/acsami.8b20616","article-title":"Localized light-Au-hyperthermia treatment for precise, rapid, and drug-free blood clot lysis","volume":"11","author":"Dong","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"2026082319572044100_ehag432-B130","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.2147\/IJN.S235518","article-title":"A peptide-functionalized magnetic nanoplatform-loaded melatonin for targeted amelioration of fibrosis in pressure overload-induced cardiac hypertrophy","volume":"15","author":"Zhao","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"2026082319572044100_ehag432-B131","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1186\/s12951-024-03047-6","article-title":"An antioxidant nanozyme for targeted cardiac fibrosis therapy post myocardial infarction","volume":"22","author":"Gu","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"2026082319572044100_ehag432-B132","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1172\/JCI113314","article-title":"Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure","volume":"81","author":"Edwards","year":"1988","journal-title":"J Clin Invest"},{"key":"2026082319572044100_ehag432-B133","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201701276","article-title":"Drug-loaded multifunctional nanoparticles targeted to the endocardial layer of the injured heart modulate hypertrophic signaling","volume":"13","author":"Ferreira","year":"2017","journal-title":"Small"},{"key":"2026082319572044100_ehag432-B134","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.biomaterials.2016.03.046","article-title":"In vitro and in vivo assessment of heart-homing porous silicon nanoparticles","volume":"94","author":"Ferreira","year":"2016","journal-title":"Biomaterials"},{"key":"2026082319572044100_ehag432-B135","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.1038\/s41467-024-49901-x","article-title":"Single dose of intravenous miR199a-5p delivery targeting ischemic heart for long-term repair of myocardial infarction","volume":"15","author":"Chen","year":"2024","journal-title":"Nat Commun"},{"key":"2026082319572044100_ehag432-B136","doi-asserted-by":"publisher","first-page":"1013910","DOI":"10.3389\/fchem.2022.1013910","article-title":"Precise dapagliflozin delivery by cardiac homing peptide functionalized mesoporous silica nanocarries for heart failure repair after myocardial infarction","volume":"10","author":"You","year":"2022","journal-title":"Front Chem"},{"key":"2026082319572044100_ehag432-B137","doi-asserted-by":"publisher","first-page":"114460","DOI":"10.1016\/j.colsurfb.2024.114460","article-title":"Platelet-mimicking nanoparticles loaded with diallyl trisulfide for mitigating myocardial ischemia-reperfusion injury in rats","volume":"248","author":"Chen","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2026082319572044100_ehag432-B138","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2217\/nnm-2020-0404","article-title":"Erythrocyte membrane coated nanoparticle-based control releasing hydrogen sulfide system protects ischemic myocardium","volume":"16","author":"Huang","year":"2021","journal-title":"Nanomedicine"},{"key":"2026082319572044100_ehag432-B139","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1016\/j.apsb.2023.08.021","article-title":"Hippo pathway-manipulating neutrophil-mimic hybrid nanoparticles for cardiac ischemic injury via modulation of local immunity and cardiac regeneration","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"2026082319572044100_ehag432-B140","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/biomimetics10030141","article-title":"Cardiac cell membrane-coated nanoparticles as a potential targeted delivery system for cardiac therapy","volume":"10","author":"Pikwong","year":"2025","journal-title":"Biomimetics"},{"key":"2026082319572044100_ehag432-B141","doi-asserted-by":"publisher","first-page":"121028","DOI":"10.1016\/j.biomaterials.2021.121028","article-title":"Direct in vivo reprogramming with non-viral sequential targeting nanoparticles promotes cardiac regeneration","volume":"276","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"key":"2026082319572044100_ehag432-B142","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202404979","article-title":"Targeted anti-inflammatory nanozymes with pro-angiogenic activity for myocardial infarction therapy","volume":"14","author":"Yang","year":"2025","journal-title":"Adv Healthc Mater"},{"key":"2026082319572044100_ehag432-B143","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202300426","article-title":"Progress on physical field-regulated micro\/nanomotors for cardiovascular and cerebrovascular disease treatment","volume":"7","author":"You","year":"2023","journal-title":"Small Methods"},{"key":"2026082319572044100_ehag432-B144","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301440","article-title":"Biomimetic and NOS-responsive nanomotor deeply delivery a combination of MSC-EV and mitochondrial ROS scavenger and promote heart repair and regeneration","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv Sci"},{"key":"2026082319572044100_ehag432-B145","doi-asserted-by":"publisher","first-page":"12573","DOI":"10.1021\/acsnano.3c02781","article-title":"Chemotactic NO\/H(2)s nanomotors realizing cardiac targeting of G-CSF against myocardial ischemia-reperfusion injury","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"key":"2026082319572044100_ehag432-B146","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41565-024-01681-7","article-title":"Oral mitochondrial transplantation using nanomotors to treat ischaemic heart disease","volume":"19","author":"Wu","year":"2024","journal-title":"Nat Nanotechnol"},{"key":"2026082319572044100_ehag432-B147","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1021\/acs.nanolett.0c00752","article-title":"A nanoprimer to improve the systemic delivery of sirna and mRNA","volume":"20","author":"Saunders","year":"2020","journal-title":"Nano Lett"},{"key":"2026082319572044100_ehag432-B148","doi-asserted-by":"publisher","first-page":"15191","DOI":"10.1021\/acsnano.1c05713","article-title":"Density of conjugated antibody determines the extent of fc receptor dependent capture of nanoparticles by liver sinusoidal endothelial cells","volume":"15","author":"Kappel","year":"2021","journal-title":"ACS Nano"},{"key":"2026082319572044100_ehag432-B149","doi-asserted-by":"publisher","first-page":"121000","DOI":"10.1016\/j.biomaterials.2021.121000","article-title":"Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment","volume":"275","author":"Wei","year":"2021","journal-title":"Biomaterials"},{"key":"2026082319572044100_ehag432-B150","doi-asserted-by":"publisher","first-page":"218","DOI":"10.7150\/thno.38198","article-title":"Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium","volume":"10","author":"Wan","year":"2020","journal-title":"Theranostics"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/32\/4410\/68518889\/ehag432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/32\/4410\/68518889\/ehag432.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T23:57:30Z","timestamp":1787529450000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/32\/4410\/8707103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":150,"journal-issue":{"issue":"32","published-online":{"date-parts":[[2026,6,12]]},"published-print":{"date-parts":[[2026,8,24]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag432","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,21]]},"published":{"date-parts":[[2026,6,12]]}}}